** Shares of Australia's Cogstate CGS.AX rise as much as 7.9% to A$2.31, their biggest intraday pct gain since February 18
** Stock touches its highest level since March 11
** Neuroscience tech firm says sales contracts executed during 3Q26 totalled A$25.4 million ($17.94 million)
** Expects contracted revenue for 2H26 of A$29.1 million, up from A$21.7 million since under contract from Dec 2025
** Expects contracted revenue for FY27 at A$35.6 million
** Stock up 1.78% YTD, including the day's moves
($1 = 1.4156 Australian dollars)
(Reporting by Aamir Sheik Khalid in Bengaluru)
((Aamir.SheikKhalid@thomsonreuters.com))